Early onset of ulcerative colitis: Long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 46, Issue 5, 2008, Pages 534-538

  Lindberg, Jan ^a,b   Stenling, Roger ^c   Palmqvist, Richard ^c   Rutegård, Jörgen ^b,d  

^a Clinic of Ophthalmology   (Sweden)

^b Department of Surgical and Perioperative Sciences   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Colorectal cancer; Early onset; Primary sclerosing cholangitis; Ulcerative colitis

Indexed keywords

DNA;

ADOLESCENT; ADULT; ANEUPLOIDY; ARTICLE; CANCER RISK; CHILD; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE DURATION; DISEASE SURVEILLANCE; DYSPLASIA; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MALE; MEDICAL RECORD; ONSET AGE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; ULCERATIVE COLITIS; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL TUMOR; HOSPITALIZATION; PATHOLOGY; PRECANCER; RISK FACTOR; SCLEROSING CHOLANGITIS;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; CHOLANGITIS, SCLEROSING; COHORT STUDIES; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PRECANCEROUS CONDITIONS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 48249092722     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31815a98ef     Document Type: Article

References (22)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
2. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988;29:206-17.
3. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 1990;18:1228-33.
4. Jess T, Lofthus EVJr, VelayosFS, etal. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology 2006;4:1039-46.
5. Winther KV, Jess T, Langholz E, et al. Long-term risk of cancer in ulcerative colitis: a population based study from Copenhagen County. Clin Gastroenterol Hepatol 2004;12:1088-95.
6. Olsson R, Danielsson A, Jarnerot G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;1:1319-23.
7. Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 2003;10:2300-7.
8. Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001;4:1116-22.
9. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995;14:924-33.
10. Langholz E, Munkholm P, Krasilnikoff PA, et al. Inflammatory bowel diseases with onset in childhood: clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 1997;2: 139-47.
11. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr 2005; 1:1-7.
12. Perminow G, Frigessi A, Rydning A, et al. Incidence and clinical presentation of IBD in children: comparison between prospective and retrospective data in a selected Norwegian population. Scand J Gastroenterol 2006;41:1433-9.
13. Ahsgren L, Jonsson B, Stenling R, et al. Prognosis after early onset of ulcerative colitis: a study from an unselected patient population. Hepatogastroenterology 1993;5:467-70.
14. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
15. Lindberg JO, Stenling RB, Rutegard JN. DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis. Br J Surg 1999;7:947-50.
16. Devroede GJ, Taylor WF, Sauer WG, et al. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971;1:17-21.
17. Turunen P, Kolho KL, Auvinen A, et al. Incidence of inflammatory bowel disease in Finnish children, 1987-2003. Inflamm Bowel Dis 2006;8:677-83.
18. Ba'ath ME, Mahmalat M, Smith NP, et al. Surgical management of inflammatory bowel disease. Arch Dis Child 2007;92:312-6.
19. Sedgwick DM, Barton JR, Hamer-Hodges DW, et al. Population-based study of surgery in juvenile onset ulcerative colitis. Br J Surg 1991;2:176-8.
20. Lim CH, Dixon MF, Vail A, et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 2003;8: 1127-32.
21. Shetty K, Rybicki L, Brzezinski A, et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999;6:1643-9.
22. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;5:1611-20.